Hepatitis
C Drugs Market will register a CAGR of % during 2020-2024. The market’s
growth momentum will Accelerate.
Increasing demand for direct-acting antivirals | High prevalence of
hepatitis C | Rising number of patient support initiatives will be one of the
major factors driving the growth of this market. Additionally, key Hepatitis C
Drugs Market trends such as the Rising number of patient support initiatives
will also influence market growth during the forecast period.
Hepatitis C Drugs Market Size
Get a FREE sample for more insights on the
growth and the market share of various regions
During the forecast period, the Hepatitis C Drugs Market size will grow by $
252.89 mn.
Hepatitis C Drugs Market : Vendors
The market is fragmented and owing to the growth opportunities, the level of
competition among the companies in this market space will intensify further.
are some of the major companies in the Hepatitis C Drugs Market. Though the
forecast period offers opportunities for vendors to increase their market
share, factors such as the High cost of drugs | Poor diagnosis | Side
effects of available drugs will also challenge the growth of the
companies.
AbbVie Inc. | Astellas Pharma Inc. | Bristol-Myers Squibb Co. | Cipla Inc. |
F. Hoffmann-La Roche Ltd. | Gilead Sciences Inc. | GlaxoSmithKline Plc |
Johnson & Johnson | Merck & Co. Inc. | Vertex Pharmaceuticals Inc..list
are some of the companies covered in Technavio’s Hepatitis C Drugs Market
report for 2021-2025.
Hepatitis C Drugs Market : Region-level Analysis
The report identifies region-level market dynamics, developments, and key
markets. The regional level analysis also identifies the market share, growth
momentum, and key leading countries in the Hepatitis C Drugs Market.
The Asia will account for the largest Hepatitis C Drugs Market share
and during 2021-2025, the region will contribute to 47% of the market’s growth.
In addition to regions and the key companies involved, Technavio’s Hepatitis
C Drugs Market report also analyzes the market by Combination therapy | Monotherapy
| North America | Europe | Asia | ROW.comma
Our Custom Research Solutions can provide
tailored Hepatitis C Drugs Market information to meet
your specific requirements.
No comments:
Post a Comment